Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity
- PMID: 1122150
Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity
Abstract
Five patients with mycosis fungoides who had developed contact dermatitis to a nitrogen mustard, mechlorethamine hydrochloride, even in low concentrations (1 to 5 mg/100 ml), received daily total-body applications of extremely dilute solutions (0.01 to 0.1 mg/100 ml) of mechlorethamine. The concentrations of the drug were approximately doubled weekly if the patient could tolerate it, or they were raised more slowly if the patient could not. Attempts to desensitize one patient were discontinued since he was unable to tolerate a greater concentration than 1.0 mg/100 ml after trying for one year. Another patient was able to tolerate a concentration of 3 mg/100 ml after three months, at which time his skin had completely cleared and treatment was stopped. Three other patients were desensitized during a period of 8 to 13 months to the point of tolerating the full therapeutic concentration used in our clinic (20 mg/100 ml) without experiencing dermatitis or pruritus.
Similar articles
-
The treatment of mycosis fungoides with ointment-based mechlorethamine.Arch Dermatol. 1982 Apr;118(4):234-7. Arch Dermatol. 1982. PMID: 7065680
-
Intravenous desensitization to mechlorethamine in patients with psoriasis.Arch Dermatol. 1976 Aug;112(8):1113-4. Arch Dermatol. 1976. PMID: 952529
-
Topical nitrogen mustard in mycosis fungoides.Int J Clin Pharmacol Res. 1985;5(3):193-8. Int J Clin Pharmacol Res. 1985. PMID: 4018954
-
Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.Int J Dermatol. 1984 Apr;23(3):180-6. doi: 10.1111/j.1365-4362.1984.tb04507.x. Int J Dermatol. 1984. PMID: 6373639 Review. No abstract available.
-
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.Drug Des Devel Ther. 2018 Jan 31;12:241-254. doi: 10.2147/DDDT.S137106. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29440874 Free PMC article. Review.
Cited by
-
Management of mycosis fungoides.J R Soc Med. 1979 Oct;72(10):717-8. doi: 10.1177/014107687907201003. J R Soc Med. 1979. PMID: 552428 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources